Imagine feeling like you're trying to breathe through a straw, even when you're just sitting still. A simple walk across the room leaves you gasping for air. The breath that once felt effortless now ...
Several weeks after reporting positive results for nerandomilast for idiopathic pulmonary fibrosis, Boehringer Ingelheim reported positive results from a similar phase 3 trial assessing its PDE4B ...
1don MSN
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
Patients with progressive pulmonary fibrosis who received nerandomilast showed improved forced vital capacity from baseline ...
Adults with progressive pulmonary fibrosis met the primary endpoint of absolute change in FVC with 52-week oral nerandomilast ...
Frontotemporal dementia (FTD) Who gets frontotemporal dementia? You are here: Getting a diagnosis of frontotemporal dementia Treatment and support for frontotemporal dementia Frontotemporal dementia ...
The following is a summary of “Development of the pulmonary fibrosis, pulmonary vascular resistance, six minute walk distance, B-type natriuretic peptide, age (PVD-B65) risk score for patients with ...
Nerandomilast, an oral phosphodiesterase 4B inhibitor, hit the primary endpoint in a Phase III trial in progressive pulmonary ...
Topline data from FIBRONEERâ„¢-ILD show that the investigational compound nerandomilast met its primary endpoint, which was the absolute change ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback